Stéphane Méry

Manufactures and installs temperature monitoring systems

Bloomsbury Bioseed Fund invests in companies located in the United Kingdom. The firm focuses on a broad range of sectors. It participates in early-stage transactions.

Beringea is an active manager which invests in dynamic businesses led by exceptional management in the healthcare, media, brands and intellectual property sectors, partnering with investee businesses to provide resources to develop strategy, evaluate growth opportunities, solve problems and build value. Their ProVen VCT invests in a diversified portfolio of unquoted and AIM-listed companies with the potential for significant value increases. After investing, the firm remains closely involved in the investee businesses, aiming to add value wherever possible and seeking to identify opportunities for profitable exits as the company's value increases. The firm's PGI VCT specializes in early-stage and growth company investments across a range of sectors. Beringea's InvestCare Partners, LP provides equity to medium-sized, privately owned mid- to late-stage US healthcare businesses, typically investing between $2 and $5 million. Their Global Rights Fund II invests in all growth stages of US and UK media, content, brands, enabling technology and intellectual property rights companies, seeking to exploit intellectual property rights across media platforms. Beringea typically invests $1-$5 million in Global Rights Fund II companies.

Develops pharmaceutical products for vascular diseases

AGI-VC investing in small and mid-sized companies in the United Kingdom. It invests in both public& private companies. It provides equity and convertible loans financing for growth/later stage capital requirements.